A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
A phase 1/2 trial of Adebrelimab, SHR-8068, Carboplatin in non-small-cell lung cancer and small-cell lung cancer, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., now recruiting.
Overview
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC is a phase 1/2 interventional study registered as NCT06754930 by Suzhou Suncadia Biopharmaceuticals Co., Ltd., with 400 participants planned, started 2025-02-18 and due to reach its primary completion in 2027-12. Interventions recorded: SHR-1826, SHR-1316, SHR-9839, SHR-8068, Ametinib mesylate. Conditions listed: Non-small Cell Lung Cancer (NSCLC). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer.
- TrialA Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Carboplatin.
- TrialA Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Carboplatin.
- TrialA Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
Shares Jiangsu Hengrui Pharmaceuticals, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals.
- TrialA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Carboplatin, Small-cell lung cancer.
- TrialA Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Carboplatin, Small-cell lung cancer.
- TrialA Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals.